Digital Science has announced a partnership with Zhipu.AI to conduct data challenges and collaborate in building a COVID-19 information portal.

Siemens Healthineers has announced the availability of its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes COVID-19.

Scientists on Standby is a portal enabling scientists with relevant skills and experience to volunteer their time, expertise and support for COVID-19 screening and testing.

OXGENE™ and The Native Antigen Company have announced a collaboration to scale up their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines.

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

PCR Biosystems are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises.

MicrosensDx has announced that the test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs has now been assessed for clinical performance

Optibrium™ and Intellegens™ have successfully completed phase 2 of a global challenge aimed at developing and testing novel antimalarial compounds.

SomaLogic has launched a new initiative to deploy their proteomic technology against the coronavirus pandemic.

Wales’ leading organization for healthcare innovation is calling on companies and innovators from across the country to join the fight against coronavirus.